Abstract
No public abstract is available from the verified source records.
Jean‐Michel Azorin, Pierre‐Michel Llorca, Nicolas Despiégel, Patrice Verpillat
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Mechanisms of action of antidepressants : new data from Escitalopram
2003
Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients
10.4088/jcp.v63n0410 · 2002
Unresolved referenced work
Kept as external metadata until matched
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care
10.1097/00004850-200205000-00001 · 2002
Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care
10.1097/00004850-200307000-00003 · 2003
10.1080/13651500310003408
10.1080/13651500310003408
Practice guidelines for major depressive disorder in adults
1993
The role of venlafaxine in rational antidepressant therapy
1994
Efficacy of fluvoxamine in severe depression
10.2165/00003495-199200432-00006 · 1992
10.1016/s0924-977x(98)00048-0
10.1016/s0924-977x(98)00048-0
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Treatment of severe depression
2000
Controversies in the diagnosis and treatment of severe depression
10.4088/jcp.v57n1111 · 1996
Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales
10.1192/bjp.148.5.599 · 1986
Efficacy of SSRIs and newer antidepressants in severe depression : comparison with TCAs
10.4088/jcp.v60n0511 · 1999
Escitalopram continuation treatment prevents relapse of depressive episode
10.4088/jcp.v65n0107 · 2004
Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial
10.3109/10401239309148983 · 1993
Fluoxetine and desipramine in major depressive disorder
10.1097/00004714-199310000-00002 · 1993
A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients
10.1111/j.1600-0447.1994.tb01533.x · 1994
The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats
10.1016/s0028-3908(03)00138-2 · 2003
Assessing antidepressant activity in rodents : recent developments and future needs
10.1016/s0165-6147(02)02017-5 · 2002
Escitalopram (S-enantiomer of citalopram) : clinical efficacy and onset of action predicted from a rat model
10.1034/j.1600-0773.2001.d01-118.x · 2001
Recovery and major depression : factors associated with twelve-month outcome
10.1176/ajp.149.1.93 · 1992
The treatment of severe depression : is there an efficacy gap between SSRI and TCA antidepressant generations ?
1994
Severe depression : is there a best approach ?
10.2165/00023210-200115100-00003 · 2001
Antidepressant effectiveness in severe depression and melancholia
1999
Treatment of severe depression with the selective serotonin reuptake inhibitors
10.1002/(sici)1520-6394(1996)4:4<182::aid-da4>3.0.co;2-h · 1996
Is a cut-off score a suitable measure of treatment outcome in shirt-term trials in depression ? A methodological meta-analysis
10.1002/hup.470080503 · 1993
No additional external references are available.